Ventyx Biosciences's total assets for Q4 2024 were $276.56M, a decrease of -8.15% from the previous quarter. VTYX total liabilities were $22.52M for the fiscal quarter, a 0.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.